
Wednesday, April 20, 2022 7:43:11 PM
7:13 am ET April 18, 2022 (Benzinga) Print
Raymond James analyst Timur Ivannikov initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $19.
Latest Ratings for GOSS DateFirmActionFromTo
Nov 2021SVB LeerinkMaintainsOutperform Aug 2021SVB LeerinkMaintainsOutperform Mar 2021HC Wainwright & Co.ReiteratesBuy
New York Yankees and Duke Basketball
Recent GOSS News
- Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs • Business Wire • 10/03/2023 08:08:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 09:00:39 PM
- Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023 • Business Wire • 09/07/2023 11:44:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/29/2023 04:15:28 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/28/2023 08:29:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 08/21/2023 08:01:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/18/2023 12:41:48 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/18/2023 12:38:27 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 08/17/2023 08:01:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:03:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:01:50 PM
- Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update • Business Wire • 08/08/2023 08:01:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 07/28/2023 07:46:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2023 08:03:44 PM
- Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results • Business Wire • 07/24/2023 08:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 08:01:04 PM
- Gossamer Bio Announces $212 Million Private Placement Financing • Business Wire • 07/20/2023 11:56:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 11:50:19 AM
- Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference • Business Wire • 05/18/2023 11:05:00 AM
- Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update • Business Wire • 05/09/2023 08:01:00 PM
- Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update • Business Wire • 03/17/2023 11:31:00 AM
- Gossamer Bio (GOSS) Gets a Buy from H.C. Wainwright • TipRanks • 12/08/2022 11:15:35 AM
- UBS Keeps Their Buy Rating on Gossamer Bio (GOSS) • TipRanks • 12/07/2022 04:25:48 PM
- Goldman Sachs Sticks to Their Buy Rating for Gossamer Bio (GOSS) • TipRanks • 12/07/2022 04:25:31 PM
FEATURED Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • Oct 3, 2023 8:50 AM
Strategic Joint Venture Signed by Santo Mining Corp. and Planta Vida S.A.S. • SANP • Oct 3, 2023 3:00 PM
Good Gaming, Inc. Announces Galactic Acres™ as Its First Mobile Game Integrated with Web3 Technology • GMER • Oct 3, 2023 8:30 AM
HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • HLYK • Oct 3, 2023 8:00 AM
Nate's Food Co Successfully Completes Cancellation of 1 Billion Common Shares, Paving the Way for a Bright Future • NHMD • Oct 3, 2023 8:00 AM
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • BLEG • Oct 3, 2023 8:00 AM